EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)

Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen–Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial

Philipp Krausewitz, Markus Essler, Florian C Gaertner, Ulrike Attenberger, Julian A Luetkens, Glen Kristiansen, Marit Bernhardt, Carsten-Henning Ohlmann, Michael Anspach, Matthias Schmid, Robert Nemeth, Jennifer Schmitz und 3 weitere

Journal of Nuclear Medicine · 2026-01 · 67 (1) · 60-66

DOI: 10.2967/jnumed.125.271344 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 06.11.2025. Verfasst von Philipp Krausewitz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany; Philipp.Krausewitz@ukbonn.de. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Prostatic Neoplasms, Glutamate Carboxypeptidase II, Antigens, Surface. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyProstatic NeoplasmsGlutamate Carboxypeptidase IIAntigens, SurfaceClinical Decision-MakingImage-Guided BiopsyHumansMaleAgedNeoplasm StagingMiddle AgedProspective Studies

Stichwörter der Autor:innen

MRIPSMA PET/CTfusion prostate biopsyprostate cancertherapy changes

Substanzen

Glutamate Carboxypeptidase IIAntigens, SurfaceFOLH1 protein, human

Autor:innen und Institutionen

  • Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany; Philipp.Krausewitz@ukbonn.de.
  • Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
  • Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
  • Institute of Pathology, University Hospital Bonn, Bonn, Germany.
  • Department of Urology, Johanniter Hospital Bonn, Bonn, Germany; and.
  • Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany.

Zitieren

APA

Krausewitz, P., Essler, M., Gaertner, F. C., Attenberger, U., Luetkens, J. A., Kristiansen, G., Bernhardt, M., Ohlmann, C. H., Anspach, M., Schmid, M., Nemeth, R., Schmitz, J., Hauser, S., Ellinger, J., & Ritter, M. (2026). Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen–Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial. Journal of Nuclear Medicine, 67(1), 60-66. https://doi.org/10.2967/jnumed.125.271344

Vancouver

Krausewitz P, Essler M, Gaertner FC, Attenberger U, Luetkens JA, Kristiansen G, et al. Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen–Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial. Journal of Nuclear Medicine. 2026;67(1):60-66. doi:10.2967/jnumed.125.271344

BibTeX
@article{Krausewitz2026,
  author = {Krausewitz, Philipp and Essler, Markus and Gaertner, Florian C and Attenberger, Ulrike and Luetkens, Julian A and Kristiansen, Glen and Bernhardt, Marit and Ohlmann, Carsten-Henning and Anspach, Michael and Schmid, Matthias and Nemeth, Robert and Schmitz, Jennifer and Hauser, Stefan and Ellinger, Joerg and Ritter, Manuel},
  title = {Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen–Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial},
  journal = {Journal of Nuclear Medicine},
  year = {2026},
  volume = {67},
  number = {1},
  pages = {60--66},
  doi = {10.2967/jnumed.125.271344}
}
Kostenlos starten →